Mycophenolate mofetil: Emerging as a potential human teratogen

Research output: Contribution to journalShort surveypeer-review

5 Scopus citations


QUESTION: One of my female patients conceived 2 years after renal transplant while using mycophenolate mofetil. She only realized she was pregnant at 14 weeks of gestation. How should I advise her? ANSWER: Several recent case series show increased malformation rates with mycophenolate mofetil. Specifically, the repeated occurrence of phenotypic presentations of ear malformations, cleft lip and palate, and other malformations suggest that this is not by chance alone.

Original languageEnglish
Pages (from-to)1112-1113
Number of pages2
JournalCanadian Family Physician
Issue number8
StatePublished - Aug 2008


Dive into the research topics of 'Mycophenolate mofetil: Emerging as a potential human teratogen'. Together they form a unique fingerprint.

Cite this